Latest "Cardiovascular Consultants, Ltd." News Stories

23:15 EDT 21st July 2018 | BioPortfolio

Here are the most relevant search results for "Cardiovascular Consultants, Ltd." found in our extensive news archives from over 250 global news sources.

More Information about Cardiovascular Consultants, Ltd. on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Cardiovascular Consultants, Ltd. for you to read. Along with our medical data and news we also list Cardiovascular Consultants, Ltd. Clinical Trials, which are updated daily. BioPortfolio also has a large database of Cardiovascular Consultants, Ltd. Companies for you to search.

Showing "Cardiovascular Consultants" News Articles 1–25 of 2,500+

Friday 20th July 2018

Native Cardio, Inc. CEO Dr. Joseph Pergolizzi Retires from Johns Hopkins University to Focus on Advanced Atrial Fibrillation Solutions

Dr. Joseph V. Pergolizzi, Jr., CEO of Native Cardio, Inc., will concentrate his efforts on developing groundbreaking medical devices for cardiology patients after retiring and resigning as a part-time adjunct assistant professor in the Department of Medicine at Johns Hopkins University School of Medicine. NAPLES, Fla. (PRWEB) July 20, 2018 Dr. Joseph V. Pergolizzi, Jr., CEO of Native Cardio, Inc....

Amgen and Cedars-Sinai Collaborate on Research, Health Service Redesign and Outcomes-Based Care

THOUSAND OAKS, Calif. and LOS ANGELES, July 19, 2018 /PRNewswire/ — Amgen (NASDAQ:AMGN) and Cedars-Sinai Medical Center today announced a partnership to help support the improvement of healthcare quality in the treatment of multiple therapeutic areas that could include oncology, cardiovascular disease, osteoporosis and migraine. The organizations intend to jointly undertake research ...

Koutif Therapeutics Confirms Clinical Candidate Drug

Company Expects to File IND Application in Late 2018 Koutif Therapeutics today announced that KT-1002, which has been selected as its lead compound, has reached clinical candidate status for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn’s Disease, after successfully completing IND-enabling studies. The biotech st...

Loma Linda University Research Suggests the Key to Living a Long Life Lies in the Behaviors Started as Young Children

Adopting eight key behaviors during childhood can help people extend their lives and fight off the inflammation often associated with life’s stressors. LOMA LINDA, Calif. (PRWEB) July 20, 2018 According to a new study from researchers at Loma Linda University, the key to living a long life lies in the behaviors started as young children. The study, published in The Permanente Journal, looked at...

Cardiovascular disease: Improving cardiomyocyte contractility

Omega-3 Fatty Acids Disappoint in Cardiovascular Protection

Although omega-3 fatty acids are widely used for protection against cardiovascular disease and related mortality, a Cochrane review challenges their' beneficial role, finding little, if any, protective benefit. Medscape Medical News

Dr. Reddy’s Announces the Launch of Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg in the U.S. Market

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg, an over-the-counter (OTC) therapeutic equivalent generic version of Nexium® 24HR Capsules in the United States market as ap...

Thursday 19th July 2018

Amgen And Cedars-Sinai Partner For Improved Healthcare Quality

First Amgen Collaboration With Academic Medical Center Focused on Research, Health Service Redesign and Outcomes-Based Care THOUSAND OAKS, Calif. and LOS ANGELES, July 19, 2018 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and Cedars-Sinai Medical Center today announced a partnership to help support the improvement of healthcare quality in the treatment of multiple therapeutic areas that could include on...

Tasly pays up to $65mm for Chinese rights to Mesoblast's MPC150IM and MPC25IC cardio candidates

Tasly Pharmaceutical Co. Ltd. licensed exclusive rights in China to develop, manufacture, and commercialize Mesoblast Ltd.'s ...

Broward Health Medical Center Designated an Aetna (Institute of Quality® / Institute of Excellence™)

Broward Health Medical Center has been designated an Aetna Institute of Quality® (IOQ) Cardiac Care Facility for the Cardiac Medical Intervention, Rhythm and Surgery programs for comprehensive heart and vascular treatment. Aetna makes information about the quality and cost of health care services available to its members to help them make informe...

Medtronic Clinical Trial to Evaluate ECG Belt for Optimizing Heart Failure Therapy

DUBLIN - July 19, 2018 - Medtronic plc (NYSE: MDT) today announced first enrollments in a new clinical trial evaluating the ECG (electrocardiography) Belt Research System (ECG Belt) as a diagnostic tool for optimizing cardiac resynchronization therapy (CRT) for patients with heart failure. The first patient enrolled in the ECG Belt for CRT Response trial was at Mercy Medical Center...

CrownBio Supports Excellence in Translational Research with Grant Award that Funds Innovative PDX Model Development in Immuno-Oncology

"Cancer Research Center of Lyon iPS novel PDX models formulate new immune cell focused strategies" SAN DIEGO, July  19, 2018  (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, is proud to announce the award of it...

Affected by the Valsartan Heart Drug Recall? Here's What to Do

THURSDAY, July 19, 2018 -- After the U.S. Food and Drug Administration announced last week that certain brands of blood pressure medicines contained a carcinogen and were being recalled, many patients may wonder what's next for their cardiovascular...

A New Edition of The American Journal of Bioethics Is Now Available

The American Journal of Bioethics (vol. 18, no. 6, 2018) is available online by subscription only. Articles include: “Performance-Enhancing Drugs, Sport, and the Ideal of Natural Athletic Performance” by Sigmund Loland “Were the “Pioneer” Clinical Ethics Consultants “Outsiders”? For Them, … Read More

Engaging Employees for Impact: Global Health Corporate Champions Improve Capacity for Public Health in Senegal

SOURCE: PYXERA Global DESCRIPTION:July 19, 2018 /3BL Media/ - For the third year in a row, The Dow Chemical Company (Dow) will send top professionals into the field as Global Health Corporate Champions (GHCC), to work with local organizations to improve health in Africa. The highly skilled professionals, which include a physician, attorney, country manager, manufacturing manager, and supply chain...

Omega 3 pills offer ‘little or no benefit’ for heart health

Increased consumption of omega 3 fats via supplements offers little or no protection on cardiovascular diseases, according to a new review of clinical evidence, led by UK researchers.

When “Good” Cholesterol Goes “Bad”

Just as beauty is in the eye of the beholder, the terms good and bad have always been somewhat subjective. For cardiovascular health, physicians regularly monitor the levels of “good” cholesterol (high-density lipoproteins or HDL) and “bad” cholesterol (low-density lipoproteins or LDL). Traditionally, cardiovascular risk is assessed by measuring levels of HDL and LDL. However, now new evid...

Protective qualities of 'good cholesterol' reduce after menopause

Levels of high density lipoprotein (HDL) may not accurately represent cardiovascular risk in older women, according to a new study.

Obesity Drug Belviq Is Heart Safe in Cardiovascular Outcome Study

Top-line 'ground-breaking' results from the CAMELLIA-TIMI 61 post-marketing study show no increased risk of cardiovascular events with lorcaserin. Full results will be reported at ESC and EASD meetings. Medscape Medical News

Wednesday 18th July 2018

Global Cardiac Monitoring Market Segmented by Treatment Type, Diseases, Technology and Geography Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $4250

The global cardiac monitoring market is expected to register a CAGR of around 4%. North America accounted for the highest market value in 2017. However, Middle East Africa is expected to register the highest CAGR during the forecast period.High Worldwide Incidence of Cardiovascular Diseases Cardiovascular diseases have become one of the primary reasons for mortality and are becoming a major conce...

Eisai reports positive topline results from CAMELLIA-TIMI61 trial

Eisai has reported positive topline results from the Cardiovascular And Metabolic Effects of Lorcaserin In Overweight And Obese Patients (CAMELLIA)...Read More... The post Eisai reports positive topline results from CAMELLIA-TIMI61 trial appeared first on Drug Development Technology.

North America Advanced Ceramics Market Segmented by Raw Material Type, Class, EndUser Industry, and Geography Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $3850

The North America advanced ceramics market was estimated at USD 16.539 billion in 2016. The market is expected to register a CAGR of 10.05% during 2018 to 2023 the forecast period. North America was the secondlargest market, accounting for around 27% of the global market share in 2017. Increasing Demand from Medical IndustryAdvanced ceramics are used in a wide range of medical devices, such as lit...

OrbusNeich gets exclusive ex-US, Japanese rights to CSI's OAS systems

Cardiovascular Systems Inc. (CSI) granted OrbusNeich exclusive rights to sell its Diamondback 360 coronary and peripheral orb...

CSI gets US rights to OrbusNeich balloons

OrbusNeich granted Cardiovascular Systems Inc. exclusive rights to sell its balloon products in the US.

Pfizer/Lilly's Tanezumab Reduces Osteoarthritis Pain, But Is It Safe?

Pfizer and Lilly said tanezumab reduced pain in a Phase III osteoarthritis study, but safety is the biggest question for...  

Quick Search


News Quicklinks